{"title":"Coronary heart disease racial disparities among older adults in the U.S.: Systematic review, 2000-2024","authors":"Sanggon Nam","doi":"10.1016/j.aggp.2025.100194","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Coronary heart disease (CHD) remains a leading cause of morbidity and mortality among older U.S. adults, with significant racial and ethnic disparities in prevalence, treatment, and outcomes. This systematic review synthesizes evidence from 44 studies published between 2000 and 2024 to examine these disparities among adults aged ≥65, focusing on prevalence, access to care, treatment quality, outcomes, contributing factors, and effective interventions.</div></div><div><h3>Methods</h3><div>The review adhered to PRISMA 2020 guidelines. A comprehensive search was conducted across six databases: PubMed, Embase, Scopus, Web of Science, CINAHL, and the Cochrane Library. Studies were included if they examined racial/ethnic differences in CHD among U.S. adults aged ≥65. Two independent reviewers screened titles and abstracts, followed by full-text review, with disagreements resolved by a third reviewer. Inter-rater reliability was assessed using Cohen’s kappa (0.85 for title/abstract, 0.90 for full-text). Quality assessment used the Newcastle-Ottawa Scale (NOS; high quality ≥7 points, moderate 4–6 points, low ≤3 points) for observational studies and the Cochrane Risk of Bias tool for randomized trials. Due to heterogeneity, a narrative synthesis was conducted, with subgroup analyses for key outcomes.</div></div><div><h3>Results</h3><div>The 44 included studies revealed persistent disparities in CHD prevalence, access, treatment, and outcomes, particularly affecting Black, Hispanic, and American Indian/Alaska Native (AI/AN) older adults. Minority groups exhibited higher CHD prevalence and risk factors (e.g., hypertension, diabetes), lower access to guideline-directed therapies, and worse outcomes, including higher readmission and mortality rates. Structural racism, socioeconomic factors, and systemic biases were key drivers. Interventions like policy reforms, community-based programs, and telehealth showed promise in reducing disparities.</div></div><div><h3>Conclusions</h3><div>Despite progress in acute care, significant disparities persist in long-term CHD management among minority older adults. Addressing social determinants, improving access to equitable care, and implementing culturally competent interventions are essential for health equity.</div></div>","PeriodicalId":100119,"journal":{"name":"Archives of Gerontology and Geriatrics Plus","volume":"2 3","pages":"Article 100194"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Gerontology and Geriatrics Plus","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S295030782500075X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Coronary heart disease (CHD) remains a leading cause of morbidity and mortality among older U.S. adults, with significant racial and ethnic disparities in prevalence, treatment, and outcomes. This systematic review synthesizes evidence from 44 studies published between 2000 and 2024 to examine these disparities among adults aged ≥65, focusing on prevalence, access to care, treatment quality, outcomes, contributing factors, and effective interventions.
Methods
The review adhered to PRISMA 2020 guidelines. A comprehensive search was conducted across six databases: PubMed, Embase, Scopus, Web of Science, CINAHL, and the Cochrane Library. Studies were included if they examined racial/ethnic differences in CHD among U.S. adults aged ≥65. Two independent reviewers screened titles and abstracts, followed by full-text review, with disagreements resolved by a third reviewer. Inter-rater reliability was assessed using Cohen’s kappa (0.85 for title/abstract, 0.90 for full-text). Quality assessment used the Newcastle-Ottawa Scale (NOS; high quality ≥7 points, moderate 4–6 points, low ≤3 points) for observational studies and the Cochrane Risk of Bias tool for randomized trials. Due to heterogeneity, a narrative synthesis was conducted, with subgroup analyses for key outcomes.
Results
The 44 included studies revealed persistent disparities in CHD prevalence, access, treatment, and outcomes, particularly affecting Black, Hispanic, and American Indian/Alaska Native (AI/AN) older adults. Minority groups exhibited higher CHD prevalence and risk factors (e.g., hypertension, diabetes), lower access to guideline-directed therapies, and worse outcomes, including higher readmission and mortality rates. Structural racism, socioeconomic factors, and systemic biases were key drivers. Interventions like policy reforms, community-based programs, and telehealth showed promise in reducing disparities.
Conclusions
Despite progress in acute care, significant disparities persist in long-term CHD management among minority older adults. Addressing social determinants, improving access to equitable care, and implementing culturally competent interventions are essential for health equity.
背景冠心病(CHD)仍然是美国老年人发病和死亡的主要原因,在患病率、治疗和结局方面存在明显的种族和民族差异。本系统综述综合了2000年至2024年间发表的44项研究的证据,以检查65岁以上成年人的这些差异,重点关注患病率、获得护理、治疗质量、结果、影响因素和有效干预措施。方法遵循PRISMA 2020指南。在六个数据库中进行了全面的搜索:PubMed, Embase, Scopus, Web of Science, CINAHL和Cochrane图书馆。如果研究在年龄≥65岁的美国成年人中检查了冠心病的种族/民族差异,则纳入研究。两位独立审稿人筛选标题和摘要,然后进行全文审稿,分歧由第三位审稿人解决。评估者间信度采用Cohen’s kappa(标题/摘要0.85,全文0.90)。质量评估采用纽卡斯尔-渥太华量表(NOS;高质量≥7分,中等4-6分,低质量≤3分)的观察性研究和随机试验的Cochrane偏倚风险工具。由于异质性,我们进行了叙事综合,并对关键结果进行了亚组分析。结果纳入的44项研究揭示了冠心病患病率、可及性、治疗和结局方面的持续差异,特别是对黑人、西班牙裔和美国印第安人/阿拉斯加原住民(AI/AN)老年人的影响。少数群体表现出更高的冠心病患病率和危险因素(如高血压、糖尿病),更少获得指导治疗,结果更差,包括更高的再入院率和死亡率。结构性种族主义、社会经济因素和系统性偏见是主要驱动因素。政策改革、社区项目和远程医疗等干预措施有望减少差距。结论:尽管在急症护理方面取得了进展,但少数民族老年人长期冠心病管理方面仍存在显著差异。解决社会决定因素,改善获得公平保健的机会,并实施具有文化竞争力的干预措施,对卫生公平至关重要。